Compound ID | 3391
EcoActive
Class: Bacteriophage and/or bacteriophage-derived product
| Agent Type: | Direct acting; Bacteriophage or bacteriphage-derived product; |
| Spectrum of activity: | Gram-negative |
| Target Pathogen: | Active against Enterobacterales; intended indication for adherent-invasive Escherichia coli in Crohn's Disease |
| Description: | Bacteriophage; contains seven double stranded DNA of Myoviridae and Siphoviridae lytic phages from environmental water |
| Institute where first reported: | Intralytix |
| Year first mentioned: | 2019 |
| Highest development stage: | Phase 2 (NCT03808103) |
| Development status: | Active |
| External links: | |
| Citation: | https://academic.oup.com/ecco-jcc/article/16/10/1617/6673800?login=true#378503399 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.